{{Chembox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 321800934
| ImageFile = Pendetide structure.svg
| ImageSize = 
| IUPACName = ''N<sup>6</sup>''-[''N''-[2-<nowiki>[[</nowiki>2-[Bis(carboxymethyl)amino]ethyl](carboxymethyl)amino]ethyl]-''N''-(carboxymethyl)glycyl]-''N<sup>2</sup>''-(''N''-glycyl-<small>L</small>-tyrosyl)-<small>L</small>-lysine
| OtherNames = 
| Section1 = {{Chembox Identifiers
| CASNo_Ref = {{cascite|correct|??}}
| CASNo = 148805-91-8
| PubChem = 

|  ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 16737038
|  SMILES = c1cc(ccc1CC(C(=O)NC(CCCCNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)O)NC(=O)CN)O
|  InChI = 1/C31H47N7O14/c32-14-24(40)34-23(13-20-4-6-21(39)7-5-20)30(50)35-22(31(51)52)3-1-2-8-33-25(41)15-37(17-27(44)45)11-9-36(16-26(42)43)10-12-38(18-28(46)47)19-29(48)49/h4-7,22-23,39H,1-3,8-19,32H2,(H,33,41)(H,34,40)(H,35,50)(H,42,43)(H,44,45)(H,46,47)(H,48,49)(H,51,52)/t22-,23-/m0/s1
|  InChIKey = ZMEWRPBAQVSBBB-GOTSBHOMBD
|  StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C31H47N7O14/c32-14-24(40)34-23(13-20-4-6-21(39)7-5-20)30(50)35-22(31(51)52)3-1-2-8-33-25(41)15-37(17-27(44)45)11-9-36(16-26(42)43)10-12-38(18-28(46)47)19-29(48)49/h4-7,22-23,39H,1-3,8-19,32H2,(H,33,41)(H,34,40)(H,35,50)(H,42,43)(H,44,45)(H,46,47)(H,48,49)(H,51,52)/t22-,23-/m0/s1
|  StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = ZMEWRPBAQVSBBB-GOTSBHOMSA-N}}
| Section2 = {{Chembox Properties
| Formula = C<sub>31</sub>H<sub>47</sub>N<sub>7</sub>O<sub>14</sub>
| MolarMass = 741.318 g/mol
| Appearance = 
| Density = 
| MeltingPt = 
| BoilingPt = 
| Solubility = }}
}}
'''Pendetide''' ('''GYK-DTPA''') is a [[chelating agent]]. It consists of [[pentetic acid]] (DTPA) linked to the [[tripeptide]] [[glycine]] (G) – <small>L</small>-[[tyrosine]] (Y) – <small>L</small>-[[lysine]] (K).<ref>[http://whqlibdoc.who.int/inn/proposed_lists/prop_INN_list67.pdf WHO Drug Information]</ref>

==Use==
The following [[monoclonal antibodies]] are linked to pendetide to chelate a [[radionuclide]], [[indium-111]]. The antibodies selectively bind to certain tumour cells, and the radioactivity is then used for imaging of the tumours.
* [[Indium (111In) capromab pendetide|Indium (<sup>111</sup>In) capromab pendetide]] (prostate cancer)
* [[Indium (111In) satumomab pendetide|Indium (<sup>111</sup>In) satumomab pendetide]] (other cancer types)

==References==
{{reflist}}

[[Category:Chelating agents]]
[[Category:Chelating agents used as drugs]]
[[Category:Carboxylic acids]]


{{pharma-stub}}